Literature DB >> 33423377

Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.

Chun Li1, Bangming Pu2, Long Gu3, Mingwei Zhang4, Hongping Shen1, Yuan Yuan1, Lishang Liao4.   

Abstract

Glioblastoma multiforme (GBM) is the most malignant primary tumour in the central nervous system, but the molecular mechanisms underlying its pathogenesis remain unclear. In this study, data set GSE50161 was used to construct a co-expression network for weighted gene co-expression network analysis. Two modules (dubbed brown and turquoise) were found to have the strongest correlation with GBM. Functional enrichment analysis indicated that the brown module was involved in the cell cycle, DNA replication, and pyrimidine metabolism. The turquoise module was primarily related to circadian rhythm entrainment, glutamatergic synapses, and axonal guidance. Hub genes were screened by survival analysis using The Cancer Genome Atlas and Human Protein Atlas databases and further tested using the GSE4290 and Gene Expression Profiling Interactive Analysis databases. The eight hub genes (NUSAP1, SHCBP1, KNL1, SULT4A1, SLC12A5, NUF2, NAPB, and GARNL3) were verified at both the transcriptional and translational levels, and these gene expression levels were significant based on the World Health Organization classification system. These hub genes may be potential biomarkers and therapeutic targets for the accurate diagnosis and management of GBM.
© 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  TCGA; WGCNA; biomarkers; glioblastoma multiforme; survival

Mesh:

Substances:

Year:  2021        PMID: 33423377      PMCID: PMC7931238          DOI: 10.1002/2211-5463.13078

Source DB:  PubMed          Journal:  FEBS Open Bio        ISSN: 2211-5463            Impact factor:   2.693


  66 in total

Review 1.  Transcriptional control of human p53-regulated genes.

Authors:  Todd Riley; Eduardo Sontag; Patricia Chen; Arnold Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

2.  SHCBP1 is required for midbody organization and cytokinesis completion.

Authors:  Eri Asano; Hitoki Hasegawa; Toshinori Hyodo; Satoko Ito; Masao Maeda; Dan Chen; Masahide Takahashi; Michinari Hamaguchi; Takeshi Senga
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.

Authors:  Wolfgang Wick; Susan Dettmer; Anne Berberich; Tobias Kessler; Irini Karapanagiotou-Schenkel; Antje Wick; Frank Winkler; Elke Pfaff; Benedikt Brors; Jürgen Debus; Andreas Unterberg; Martin Bendszus; Christel Herold-Mende; Andreas Eisenmenger; Andreas von Deimling; David T W Jones; Stefan M Pfister; Felix Sahm; Michael Platten
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

Review 4.  The biology and clinical relevance of the PTEN tumor suppressor pathway.

Authors:  Isabelle Sansal; William R Sellers
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

5.  Lack of exonic sulfotransferase 4A1 mutations in controls and schizophrenia cases.

Authors:  Aaron G Lewis; Rodney F Minchin
Journal:  Psychiatr Genet       Date:  2009-02       Impact factor: 2.458

6.  Human NUF2 interacts with centromere-associated protein E and is essential for a stable spindle microtubule-kinetochore attachment.

Authors:  Dan Liu; Xia Ding; Jian Du; Xin Cai; Yuejia Huang; Tarsha Ward; Andrew Shaw; Yong Yang; Renming Hu; Changjiang Jin; Xuebiao Yao
Journal:  J Biol Chem       Date:  2007-05-29       Impact factor: 5.157

Review 7.  Isocitrate Dehydrogenase Mutation and (R)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development.

Authors:  Lenny Dang; Shin-San Michael Su
Journal:  Annu Rev Biochem       Date:  2017-04-03       Impact factor: 27.258

Review 8.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

Authors:  Katarzyna Tomczak; Patrycja Czerwińska; Maciej Wiznerowicz
Journal:  Contemp Oncol (Pozn)       Date:  2015

9.  iRegulon: from a gene list to a gene regulatory network using large motif and track collections.

Authors:  Rekin's Janky; Annelien Verfaillie; Hana Imrichová; Bram Van de Sande; Laura Standaert; Valerie Christiaens; Gert Hulselmans; Koen Herten; Marina Naval Sanchez; Delphine Potier; Dmitry Svetlichnyy; Zeynep Kalender Atak; Mark Fiers; Jean-Christophe Marine; Stein Aerts
Journal:  PLoS Comput Biol       Date:  2014-07-24       Impact factor: 4.475

10.  Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.

Authors:  Ji'an Yang; Long Wang; Zhou Xu; Liquan Wu; Baohui Liu; Junmin Wang; Daofeng Tian; Xiaoxing Xiong; Qianxue Chen
Journal:  Front Genet       Date:  2020-03-31       Impact factor: 4.599

View more
  3 in total

1.  Glioblastoma gene network reconstruction and ontology analysis by online bioinformatics tools.

Authors:  Natalya V Gubanova; Nina G Orlova; Arthur I Dergilev; Nina Y Oparina; Yuriy L Orlov
Journal:  J Integr Bioinform       Date:  2021-11-16

Review 2.  Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors.

Authors:  Giorgia Iegiani; Ferdinando Di Cunto; Gianmarco Pallavicini
Journal:  Cell Death Dis       Date:  2021-10-18       Impact factor: 8.469

3.  Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis.

Authors:  Chirasmita Nayak; Sanjeev Kumar Singh
Journal:  ACS Omega       Date:  2022-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.